Danco asks Supreme Court to pause appeals ruling that halts mail delivery of mifepristone
Danco Laboratories has asked the U.S. Supreme Court to stay a unanimous appeals court decision that temporarily bars the mail-order distribution of mifepristone, a move that significantly limits national access to the drug and escalates a series of legal challenges to its approval and subsequent regulatory changes.